AVXL - CIK 0001314052
The table below shows ANAVEX LIFE SCIENCES CORP.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $131.75M | $101.16M | $115.77M | $120.78M | $138.76M | $139.39M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| - |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $132.99M | $102.43M | $117.14M | $124.04M | $141.53M | $144.52M |
| Accounts payable | $2.64M | $6.74M | $7.00M | $4.57M | $3.50M | $3.73M |
| Total current liabilities | - | - | - | - | - | - |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $6.37M | $11.47M | $17.38M | $13.13M | $11.75M | $9.56M |
| Retained earnings | -$388.13M | -$372.62M | -$359.38M | -$348.18M | -$324.45M | -$312.24M |
| Total equity | $126.62M | $90.96M | $99.76M | $110.92M | $129.78M | $134.96M |